Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-25-000089

Chief Operations Officer acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

English Emily · Chief Operations Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-05-12 Exercise or conversion : show line 1 in the form +7,500 $3.30 $24,750 55,226 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-05-12 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −7,500 34,369 D
Loading xslF345X05/wk-form4_1747253745.xml…